# Nitric Oxide to Treat Pulmonary Embolism

> **NCT01939301** · PHASE2 · COMPLETED · sponsor: **Indiana University** · enrollment: 78 (actual)

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** Inhaled Nitric Oxide
- **DRUG:** Sham

## Key facts

- **NCT ID:** NCT01939301
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-10-31
- **Final completion:** 2016-10-31
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2018-10-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01939301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01939301, "Nitric Oxide to Treat Pulmonary Embolism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01939301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*